Single Ascending Dose Study of PRT064445, a Factor Xa (fXa) Inhibitor Antidote
Clinical trial NCT03218241 · COMPLETED
Trial details
- NCT number
- NCT03218241
- Sponsor
- Portola Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-06-01
- Primary completion
- 2012-09-01
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.